Tarnagulla Ventures is an Australia-based venture capital firm headquartered in Melbourne that focuses on early-stage investments, particularly in life sciences and healthcare technology. The firm provides seed and venture capital to companies developing medical, biotech, and healthcare innovations with potential for commercial scaling. It typically engages in global investing activity, with a stated interest in helping portfolio companies expand into larger markets such as the United States. Tarnagulla Ventures combines capital investment with strategic support and sector expertise in healthcare and medical technologies. Its overall approach is centered on backing scientifically driven companies with strong potential for real-world medical or therapeutic impact.